Fox Christine, EVP, U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD, sold $751K of TEVA

Fox Christine EVP, U.S. Commercial

TEVA PHARMACEUTICAL INDUSTRIES LTD · $TEVA

$751K Total Value

21,258 Shares Traded

$35.31 Price / Share

63,647 Shares Owned After

2026-05-04 Filing Date

Transaction Details

Insider	Fox Christine
Title	EVP, U.S. Commercial
Company	TEVA PHARMACEUTICAL INDUSTRIES LTD
Ticker	TEVA
Transaction Type	Sale
Transaction Date	2026-04-30
Shares Traded	21,258
Price Per Share	$35.31
Total Value	$751K
Filed Date	2026-05-04
Accession Number	0001193125-26-203920

Ownership Context

Shares Owned After Transaction	63,647
Ownership Type	Direct

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-203920

Other Insider Trades — TEVA

Insider	Title	Action	Value	Date
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	sold	$3.6M	2026-06-11
Nisen Perry	Insider	traded	—	2026-06-05
BARER SOL J	Insider	traded	—	2026-06-05
Elstein Amir	Insider	traded	—	2026-06-05
MIGNONE ROBERTO	Insider	traded	—	2026-06-05
Crane Rosemary A	Insider	traded	—	2026-06-05
Satchi-Fainaro Ronit	Insider	traded	—	2026-06-05
LIEBERMAN GERALD M	Insider	traded	—	2026-06-05
Lichtenstein Chen	Insider	traded	—	2026-06-05
Zaks Tal Zvi	Insider	traded	—	2026-06-05

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for TEVA — TEVA PHARMACEUTICAL INDUSTRIES LTD →

Whisper Score — TEVA

27.6

Murmurs

Current Whisper Score

See full analysis for TEVA →

Track TEVA insider activity in real time on The Wire →

Get alerts when Fox Christine files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 19, 2026 at 07:16 UTC